Julie Cui
About Julie Cui
Julie Cui is a Senior Analyst at ClearView Healthcare Partners, specializing in pricing and market access strategy for pharmaceutical and biotech clients. She holds a Master of Science in Chemical Engineering from Columbia University and has experience in clinical and commercial opportunity assessment within the life sciences industry.
Work at ClearView Healthcare Partners
Julie Cui currently serves as a Senior Analyst at ClearView Healthcare Partners, a position she has held since 2024. Prior to this role, she worked as an Analyst at the same firm from 2022 to 2023. During her tenure, she has developed expertise in pricing and market access strategy for pharmaceutical and biotech clients. Her work involves leading projects that focus on commercial due diligence and corporate strategy, particularly for buy-side clients in the healthcare sector.
Education and Expertise
Julie Cui holds a Master of Science (M.S.) in Chemical Engineering from Columbia University. She also earned a Bachelor of Science (B.S.) in Chemical and Biomolecular Engineering from The Johns Hopkins University. Her educational background supports her specialization in clinical and commercial opportunity assessment and competitive intelligence within the life sciences industry.
Background
Before joining ClearView Healthcare Partners, Julie Cui gained valuable experience through internships at prominent companies. She interned at Genentech in 2019, focusing on Pharma Process and Technology Development, and later worked at Merck in 2020 in Oral Formulation Technologies. Additionally, she was a Neurosurgery Design Team Engineer at The Johns Hopkins University from 2019 to 2020, where she contributed to engineering projects in the medical field.
Achievements
Julie Cui has a diverse project portfolio that includes new product planning and go-to-market strategy in the medtech sector. Her experience encompasses leading projects that involve commercial due diligence and corporate strategy, showcasing her ability to navigate complex challenges in the healthcare industry. Her work has contributed to the strategic development of various pharmaceutical and biotech initiatives.